loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1999_003___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    F. Hoffmann-La Roche

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 F Hoffmann-La Roche Ltd. Basel CH (1)

    filter

    01 Glibenclamide (1)

    filter

    01 U.S.A (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    F Hoffmann-La Roche Ltd. Basel CH

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Glibenclamide

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1999-003 - Rev 01
    Withdrawn by Holder
    Chemical
    2009-11-19
    2015-07-01
    718
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-003 - Rev 01 of F Hoffmann-la Roche Ltd. Basel Ch

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-003 - Rev 01 of F Hoffmann-la Roche Ltd. Basel Ch 1

    20

    F Hoffmann-la Roche Ltd. Basel Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Glibenclamide, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-003 - Rev 01

    This Chemical Type CEP, issued on November 19, 2009, remains in force until July 01, 2015, ensuring its reliability within the pharmaceutical industry.

    Substance Number 718 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY